Keith Batchelder

Summary

Keith Batchelder MD, is the founder and CEO of Genomic Healthcare Strategies, a company focused on the changes in healthcare resulting from advances in molecular medicine. GHS provides strategy and implementation services for companies looking to enter or grow in the new markets emerging as result of predictive diagnostics and preventive medicine. Dr. Batchelder has long been interested in the intersection of the scientific, business and societal promises and challenges raised by personalized medicine. His area of expertise is in the analysis of new markets, channels, partners, and the new science supporting the rapidly evolving practice of medicine and wellness. In a career that has spanned medical research, clinical practice, and management in small and large organizations, Dr. Batchelder focuses on the practical application of healthcare innovation and its economics. He has served as chief technical officer of WorldCare International Clinical Trials, where he used biomarkers as surrogate endpoints for successful FDA approvals; as CIO of Harvard Salud Integral, where he helped to raise funding and grow a start-up HMO in Mexico City; as a principal of AMICAS, a web-based radiology system grown from concept, to a profitable medical software company; and as a staff Massachusetts General Hospital for eight years, he conducted industry sponsored research in innovative drug discovery, created novel techniques and published in peer reviewed journals. Dr. Batchelder was educated at Middlebury College, the Hahnemann University School of Medicine, received postgraduate training in Medical Informatics at The Boston VA Hospital, completed a fellowship at the Food and Drug Administration, and a master’s degree in biomaterials from New York University. Dr. Batchelder, acting on his belief in the potential of personalized medicine, is one of the first ten volunteers to have their full genomes sequenced and published online at www.personalgenomes.org